FDA Grants ‘Priority Review’ of Plant-Derived CBD Extract
FDA Grants ‘Priority Review’ of Plant-Derived CBD Extract
FDA Grants ‘Priority Review’ of Plant-Derived CBD Extract | NORML
WASHINGTON, DC — Representatives of the US Food and Drug Administration will undertake a ‘priority review‘ of data specific to the safety and efficacy of Epidiolex, a standardized, plant-derived CBD extract formulated by a British pharmaceutical company. The review is scheduled to be completed by June 27, 2018. Phase III clinical trial data shows that Epidiolex […]
FDA Grants ‘Priority Review’ of Plant-Derived CBD Extract | The Daily Chronic
Go to Source
Powered by WPeMatico